Publications by authors named "Heidi Fricker"

Claim this Profile
R
Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS Lymphoma.
Lisa K Isbell, Annika Vreden, Gabriele Ihorst, Roswitha Uibeleisen, Alexander Friedl, Heidi Fricker

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial.
Elisabeth Schorb, Lisa Kristina Isbell, Andrea Kerkhoff, Stephan Mathas, Friederike Braulke, Heidi Fricker

Lancet Haematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.
Lisa K Isbell, Roswitha Uibeleisen, Alexander Friedl, Elvira Burger, Tatja Dopatka, Heidi Fricker

BMC Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma.
Julia Wendler, Christopher P Fox, Elke Valk, Cora Steinheber, Heidi Fricker

BMC Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study.
Elisabeth Schorb, Benjamin Kasenda, Gabriele Ihorst, Florian Scherer, Julia Wendler, Heidi Fricker

Blood Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.
Elisabeth Schorb, Juergen Finke, Gabriele Ihorst, Benjamin Kasenda, Heidi Fricker

BMC Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.
Gerald Illerhaus, Benjamin Kasenda, Gabriele Ihorst, Gerlinde Egerer, Monika Lamprecht, Heidi Fricker

Lancet Haematol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
Elisabeth Schorb, Juergen Finke, Andrés J M Ferreri, Gabriele Ihorst, Kristina Mikesch, Heidi Fricker

BMC Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis